Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02)

PurposeTo analyze the efficacy and safety of transarterial chemoembolization (TACE) with apatinib (TACE-A) for the treatment of advanced hepatocellular carcinoma (HCC).MethodsData from advanced HCC patients treated with TACE-A between January 2019 and June 2022 were evaluated. The patients from 8 me...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hang Yuan, Zhen Li, Guang-Shao Cao, Fei Xu, Gang Wu, Peng-Xu Ding, Qiu-Liang Wei, Zu-Kuan Chang, Cheng Xing, Huan-Zhang Niu, Jun Yin, Quan-Jun Yao, Lin Zheng, Jin-Cheng Xiao, Cheng-Shi Chen, Hong-Tao Cheng, Deng-Wei Zong, Wei-Li Xia, Xiang Geng, Xiao-Hui Zhao, Hai-Liang Li, Hong-Tao Hu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Oncology
Subjects:	transarterial chemoembolization apatinib hepatocellular carcinoma real world overall survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1615911/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02)

Similar Items